COL22A1 expression identifies aggressive glioma and independently predicts survival through integrated multiomics and clinical validation
Abstract Background Gliomas, especially IDH‑wildtype astrocytomas, remain lethal despite multimodal therapy. Collagen type XXII alpha-1 (COL22A1) exhibits oncogenic activity in other cancers but remains underexplored in brain tumors. We asked whether its expression, cellular origin, and spatial cont...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer
2025-10-01
|
| Edice: | Discover Oncology |
| Témata: | |
| On-line přístup: | https://doi.org/10.1007/s12672-025-03723-5 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
